Hybrigenics SA

EPA:ALHYG.PA

0.0103 (EUR) • At close June 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q22011 Q42011 Q22010 Q42010 Q22009 Q42009 Q22008 Q4
Revenue 0.1920.192000.14700.0750.0750.1170.1170.05900.0190.3730.8311.6872.3182.3182.7752.7752.8112.8112.2892.2891.1281.1281.8681.8680.9342.0851.042
Cost of Revenue 0.2650.265000.0070000.0010.00100.7630.0080.3671.1161.562.0222.0222.2162.2161.8171.8172.0692.0691.7021.7020.3490.3490.1750.3770.188
Gross Profit -0.073-0.073000.1400.0750.0750.1170.1170.058-0.7630.0110.006-0.2850.1270.2960.2960.5590.5590.9950.9950.220.22-0.574-0.5741.5191.5190.7591.7080.854
Gross Profit Ratio -0.381-0.381000.95200.9990.9990.9950.9950.99500.5880.016-0.3430.0750.1280.1280.2010.2010.3540.3540.0960.096-0.509-0.5090.8130.8130.8130.8190.819
Reseach & Development Expenses 000000000005.27302.4711.9871.3631.2751.2751.548000000000000
General & Administrative Expenses 0000000.1180.1180.4010.4010.201.43500.501.1021.102001.7651.7652.0092.009001.917-1.917-0.958-1.942-0.971
Selling & Marketing Expenses 000000000.344-0.344-0.1720-1.37700.1470-0.004-0.004001.065-1.0651.303-1.303002.0582.0581.0292.1651.082
SG&A 00000.26500.1180.1180.7440.0570.0293.6480.0581.8610.3732.6021.1021.1023.5440.8382.830.73.3120.707-0.1520.1523.9740.1410.0710.2230.112
Other Expenses 001.5-20.223-0.10.040.040.79200-0.0760-0.088-0.050.0030.2940.2944.5400.68400.0090-0.01303.7860000
Operating Expenses 6.7436.743-1.520.0230.10.1590.1591.5370.0570.0298.8450.0584.2442.413.9682.7982.7983.7030.8383.5140.73.4290.7071.9330.1527.760.1410.0710.2230.112
Operating Income -0.377-0.3771.5-2-0.023-0.1-0.159-0.159-1.087-0.274-0.137-9.608-1.832-4.238-1.579-3.841-2.207-2.207-1.878-1.746-1.215-1.194-2.339-1.382-1.705-1.527-2.435-2.43-1.215-2.406-1.203
Operating Income Ratio -1.962-1.96200-0.8380-2.105-2.105-5.791-2.332-2.3320-95.511-11.362-1.9-2.277-0.952-0.952-0.677-0.629-0.432-0.425-1.022-0.604-1.512-1.354-1.304-1.301-1.301-1.154-1.154
Total Other Income Expenses Net -6.379-6.379-1.520.320.10.0180.0180.321-0.492-0.2460.676-0.1250.5080.1520.365000.081-0.0520.001-0.0210.473-0.4850.1780-0.066-0.071-0.035-0.052-0.026
Income Before Tax -6.755-6.755000.2970-0.141-0.141-0.766-0.766-0.383-8.932-1.957-3.73-1.427-3.476-2.166-2.166-1.798-1.798-1.214-1.214-1.867-1.867-1.527-1.527-2.5-2.5-1.25-2.458-1.229
Income Before Tax Ratio -35.202-35.202002.0160-1.867-1.867-6.52-6.52-6.520-102.003-10-1.717-2.06-0.934-0.934-0.648-0.648-0.432-0.432-0.816-0.816-1.354-1.354-1.339-1.339-1.339-1.179-1.179
Income Tax Expense -3.644-3.644-1.52-0.10.10.0240.024-0.7020.0940.047-0.3480.05-0.299-0.032-0.5820.0070.007-0.287-0.287-0.301-0.301-0.161-0.161-0.381-0.381-0.221-0.221-0.111-0.36-0.18
Net Income -9.423-9.4231.5-20.397-0.1-0.165-0.165-0.063-0.86-0.43-8.662-2.007-3.719-2.387-2.87-2.188-2.188-1.409-1.511-0.875-0.914-0.749-1.706-1.146-1.146-2.279-2.279-1.14-2.098-1.049
Net Income Ratio -49.105-49.105002.0170-2.185-2.185-3.929-7.318-7.3180-104.61-9.971-2.872-1.701-0.944-0.944-0.508-0.545-0.311-0.325-0.327-0.745-1.016-1.016-1.22-1.22-1.22-1.006-1.006
EPS -0.025-0.0250.006-0.0080.002-0-0.001-0.0010.017-0.021-0.011-0.19-0.05-0.1-0.065-0.078-0.06-0.06-0.06-0.05-0.037-0.039-0.039-0.091-0.081-0.079-0.173-0.177-0.088-0.174-0.087
EPS Diluted -0.025-0.0250.006-0.0080.002-0-0.001-0.0010.017-0.021-0.011-0.19-0.05-0.1-0.065-0.074-0.06-0.06-0.06-0.05-0.037-0.039-0.039-0.091-0.081-0.079-0.173-0.177-0.088-0.174-0.087
EBITDA -0.225-0.2253-40.138-0.2-0.134-0.134-1.032-0.236-0.118-8.845-1.773-4.141-0.436-3.733-1.807-1.807-1.474-1.552-0.743-0.945-2.048-1.134-1.425-1.237-1.792-1.992-0.996-1.978-0.989
EBITDA Ratio -1.174-1.17400-0.4220-1.783-1.783-5.4-2.011-2.0110-92.426-11.102-0.525-2.213-0.78-0.78-0.531-0.559-0.264-0.336-0.895-0.495-1.263-1.097-0.959-1.066-1.066-0.949-0.949